ACUT — what changed in the latest 10-Q
A section-by-section comparison of ACUT's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-14 vs the prior 10-Q · 2026-05-15
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +7 | −5 | ~8 | 46 |
| Market risk (Item 3) | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Controls & procedures | Text added/removed | 0 | 0 | ~3 | 5 |
| Risk factors | No material changes reported (points to the 10-K) | — | — | — | — |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Legal proceedings, Other information
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-14
Other Income for the three and six months ended June 30, 2026, increased to $98,400, compared to $0 for the three and six months ended June 30, 2025, due to one-off credits against supplier invoices that were deemed no longer due and payable.
Research and development expenses for the three months ended June 30, 2026, decreased to $43,712 compared to $60,204, for the three months ended June 30, 2025, primarily due to timing of spend relating to technology transfer.
Research and development expenses for the six months ended June 30, 2026, increased to $163,237 compared to $88,550, for the six months ended June 30, 2025, primarily due to duplicate invoices received from a supplier last quarter, which are offset with credit notes received, reflected in other inco…
General and administrative expenses for three and six months ended June 30, 2026, decreased to $307,261 and $673,619, respectively, compared to $341,199 and $753,261, respectively, for the three and six months ended June 30, 2025 primarily due to no payroll related bonus costs incurred in 2026.
Since our inception, we have not generated any revenue and have incurred significant operating losses. Our potential products are at various phases of development. We do not expect to generate significant revenue from product sales for several years, if at all. Pursuant to the demerger, Tiziana tran…
Text removed vs the prior filing · source: 10-Q · 2026-05-15
Research and development expenses for the three months ended March 31, 2026, increased to $119,525, compared to $28,346 for the three months ended March 31, 2025 primarily due to an increase in MSC related laboratory work and consulting.
General and administrative expenses for three months ended March 31, 2026, decreased to $366,358, compared to $412,062 for the three months ended March 31, 2025 primarily due to no payroll related bonus costs incurred in 2026.
Since our inception, we have not generated any revenue and have incurred significant operating losses. Our potential products are at various phases of development. We do not expect to generate significant revenue from product sales for several years, if at all. Pursuant to the demerger, Tiziana tran…
Cash flows (used in) provided by financing activities 372,454 321,517
Net (decrease) increase in cash and cash equivalents (1,722) 31,335
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice